Stockscreener 앱 받기
41.51
1.38%
0.565
전일 마감가:
$40.94
열려 있는:
$41.64
하루 거래량:
21,742
Relative Volume:
0.02
시가총액:
$3.35B
수익:
-
순이익/손실:
$-64.16M
주가수익비율:
-32.68
EPS:
-1.2702
순현금흐름:
$-69.06M
1주 성능:
-3.03%
1개월 성능:
+1.21%
6개월 성능:
+60.50%
1년 성능:
+44.32%
1일 변동 폭
$40.91
$41.64
1주일 범위
$40.43
$43.50
52주 변동 폭
$14.80
$46.01
Cg Oncology Inc Stock (CGON) Company Profile
명칭
Cg Oncology Inc
전화
(949) 419-6203
주소
400 SPECTRUM CENTER DRIVE, IRVINE
CGON을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CGON
Cg Oncology Inc
|
41.51 | 3.30B | 0 | -64.16M | -69.06M | -1.2702 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.61 | 114.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
750.86 | 77.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
845.23 | 54.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
400.76 | 52.52B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.54 | 42.02B | 447.02M | -1.18B | -906.14M | -6.1812 |
Cg Oncology Inc Stock (CGON) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-11 | 개시 | Wedbush | Outperform |
| 2025-11-24 | 개시 | Truist | Buy |
| 2025-10-08 | 개시 | Guggenheim | Buy |
| 2025-08-19 | 개시 | Piper Sandler | Overweight |
| 2025-07-10 | 재개 | Goldman | Buy |
| 2025-05-02 | 개시 | JP Morgan | Overweight |
| 2025-04-16 | 개시 | Scotiabank | Sector Perform |
| 2025-01-07 | 개시 | TD Cowen | Buy |
| 2024-10-24 | 개시 | UBS | Buy |
| 2024-09-23 | 개시 | RBC Capital Mkts | Outperform |
| 2024-08-28 | 개시 | ROTH MKM | Buy |
| 2024-06-28 | 개시 | BofA Securities | Buy |
| 2024-02-20 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-02-20 | 개시 | Goldman | Neutral |
| 2024-02-20 | 개시 | Morgan Stanley | Overweight |
| 2024-02-14 | 개시 | H.C. Wainwright | Buy |
모두보기
Cg Oncology Inc 주식(CGON)의 최신 뉴스
CG Oncology appoints Rossi to its Board of Directors - MSN
OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases Shares of 26,000 CG Oncology, Inc. $CGON - MarketBeat
CG Oncology (NASDAQ:CGON) Earns Outperform Rating from Analysts at Wedbush - MarketBeat
CG Oncology initiated with an Outperform at Wedbush - TipRanks
How Positive Cretostimogene Trial Updates And Leadership Moves At CG Oncology (CGON) Have Changed Its Investment Story - Yahoo Finance
CG Oncology, Inc. (CGON) is a Buy on Cancer Treatment Development: Truist Securities - Insider Monkey
CG Oncology (CGON) Valuation Check After Strong Late-Breaking Cretostimogene Bladder Cancer Trial Results - Sahm
Promising Prospects for CG Oncology, Inc.: Buy Rating Backed by Cretostimogene’s Potential in NMIBC Market - TipRanks
CG Oncology (NASDAQ:CGON) Sets New 1-Year HighStill a Buy? - MarketBeat
Cg Oncology Inc. (CGON) Live Share Price, Invest From India - INDmoney
CG Oncology, Inc. (CGON) stock price, news, quote and history - Yahoo Finance UK
CG Oncology Incannounced topline data from Bond-003 cohort P and first results from Core-008 cohort A - marketscreener.com
New Cretostimogene Grenadenorepvec Data Highlight its Potential to Become the Backbone Therapy for High-Risk Non-Muscle Invasive Bladder Cancer - The Manila Times
CG Oncology Reports Promising Efficacy and Safety Data for Cretostimogene in High-Risk Non-Muscle Invasive Bladder Cancer Trials - Quiver Quantitative
CG Oncology (NASDAQ: CGON) posts 83.7% CR, no Grade 3+ AEs in NMIBC trial data - Stock Titan
Schroder Investment Management Group Acquires 155,737 Shares of CG Oncology, Inc. $CGON - MarketBeat
Will CG Oncology’s (CGON) Board Refresh and Cretostimogene Data Shape Its Bladder Cancer Strategy? - Sahm
Muscle Invasive Bladder Cancer Market to Reach New Heights in Growth by 2034, DelveInsight Predicts | CG Oncology, Pfizer, UroGen Pharma, Janssen R&D, LLC, Protara Therapeutics, Binhui Biopharma - The Globe and Mail
Muscle Invasive Bladder Cancer Market to Reach New Heights - openPR.com
Midday Stock Roundup: Tilly’s, indie Semiconductor Up - Orange County Business Journal
CG Oncology (CGON) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
CG Oncology Appoints Jim DeTore as Interim CFO - MSN
FY2025 EPS Estimates for CG Oncology Increased by Analyst - MarketBeat
A Look at CG Oncology's (CGON) Valuation Following New Clinical Trial Data Announcements - Sahm
Will CG Oncology Inc. stock beat EPS estimatesMarket Sentiment Review & Proven Capital Preservation Tips - BỘ NỘI VỤ
Guidance Update: Will CG Oncology Inc. stock beat EPS estimates2025 Key Lessons & Proven Capital Preservation Tips - moha.gov.vn
Tejara Capital Ltd Purchases New Position in CG Oncology, Inc. $CGON - MarketBeat
Midday Stock Roundup: Eledon Up 4.8% - Orange County Business Journal
Intech Investment Management LLC Acquires 6,503 Shares of CG Oncology, Inc. $CGON - MarketBeat
CG Oncology, Inc. $CGON Shares Purchased by Franklin Resources Inc. - MarketBeat
Geode Capital Management LLC Increases Stake in CG Oncology, Inc. $CGON - MarketBeat
CG Oncology Appoints Christina Rossi to Board - MSN
Why analysts upgrade CG Oncology Inc. stock2025 Analyst Calls & Long-Term Growth Stock Strategies - moha.gov.vn
CG Oncology (NASDAQ:CGON) Reaches New 12-Month HighHere's What Happened - MarketBeat
[Form 4] CG Oncology, Inc. Insider Trading Activity - Stock Titan
[Form 3] CG Oncology, Inc. Initial Statement of Beneficial Ownership - Stock Titan
CG Oncology, Inc. Announces Board and Committee Changes - marketscreener.com
CG Oncology appoints Christina Rossi to board of directors By Investing.com - Investing.com Nigeria
Promising Developments in CG Oncology’s NMIBC Treatment Drive Buy Recommendation - TipRanks
CG Oncology appoints Christina Rossi to board as Simone Song resigns - Investing.com UK
CG Oncology appoints Christina Rossi to board as Simone Song resigns By Investing.com - Investing.com South Africa
CG Oncology appoints Christina Rossi to board of directors - Investing.com India
CG Oncology Announces Board Changes - TradingView
[8-K] CG Oncology, Inc. Reports Material Event | CGON SEC FilingForm 8-K - Stock Titan
CG Oncology Appoints Christina Rossi to Board of Directors - Quiver Quantitative
CG Oncology Announces New Board Member and Board Transition - The Manila Times
CG Oncology (NASDAQ: CGON) names Rossi to board amid BLA initiation - Stock Titan
CG Oncology, Inc. $CGON Position Lifted by Foresite Capital Management V LLC - MarketBeat
CG Oncology (NASDAQ: CGON) highlights BOND-003 and CORE-008 NMIBC data at SUO meeting - Stock Titan
Truist Financial Begins Coverage on CG Oncology (NASDAQ:CGON) - MarketBeat
CG Oncology, Inc. (CGON) Has a New Rating from Truist Financial - The Globe and Mail
Cg Oncology Inc (CGON) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.56%
1.23%
자본화:
|
볼륨(24시간):